Boro-norleucine as a P1 residue for the design of selective and potent DPP7 inhibitors

被引:14
作者
Shreder, KR [1 ]
Wong, MS [1 ]
Corral, S [1 ]
Yu, ZZ [1 ]
Winn, DT [1 ]
Wu, M [1 ]
Hu, Y [1 ]
Nomanbhoy, T [1 ]
Alemayehu, S [1 ]
Fuller, SR [1 ]
Rosenblum, JS [1 ]
Kozarich, JW [1 ]
机构
[1] ActivX Biosci, La Jolla, CA 92037 USA
关键词
dipeptidyl peptidase; boro-norleucine; DPP4; FAP; DPP7; DPP8; DPP9;
D O I
10.1016/j.bmcl.2005.06.076
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dipeptide-based inhibitors with C-substituted (alkyl or aminoalkyl) alpha-amino acids in the P2 position and born-norleucine (boro-Nle) in the P1 position were synthesized. Relative to born-proline, boro-Nle as a P1 residue was shown able to significantly dial out DPP4, FAP, DPP8, and DPP9 activity. Dab-boro-Nle (4g) proved to be the most selective and potent DPP7 inhibitor with a DPP7 IC50 value of 480 pM. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4256 / 4260
页数:5
相关论文
共 23 条
[1]   Diastereoselective synthesis and configuration-dependent activity of (3-substituted-cycloalkyl)glycine pyrrolidides and thiazolidides as dipeptidyl peptidase IV inhibitors [J].
Ashton, WT ;
Dong, H ;
Sisco, RM ;
Doss, GA ;
Leiting, B ;
Patel, RA ;
Wu, JK ;
Marsilio, F ;
Thornberry, NA ;
Weber, AE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (04) :859-863
[2]   Substituted piperazines as novel dipeptidyl peptidase IV inhibitors [J].
Brockunier, LL ;
He, JF ;
Colwell, LF ;
Habulihaz, B ;
He, HB ;
Leiting, B ;
Lyons, KA ;
Marsilio, F ;
Patel, RA ;
Teffera, Y ;
Wu, JK ;
Thornberry, NA ;
Ann, AE ;
Parmee, ER .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (18) :4763-4766
[3]   Fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors [J].
Caldwell, CG ;
Chen, P ;
He, JF ;
Parmee, ER ;
Leiting, B ;
Marsilio, F ;
Patel, RA ;
Wu, JK ;
Eiermann, GJ ;
Petrov, A ;
He, HB ;
Lyons, KA ;
Thornberry, NA ;
Weber, AE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (05) :1265-1268
[4]  
Chiravuri M, 1999, J IMMUNOL, V163, P3092
[5]   Structure-activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV .1. Variation of the P-2 position of X(aa)-boroPro dipeptides [J].
Coutts, SJ ;
Kelly, TA ;
Snow, RJ ;
Kennedy, CA ;
Barton, RW ;
Adams, J ;
Krolikowski, DA ;
Freeman, DM ;
Campbell, SJ ;
Ksiazek, JF ;
Bachovchin, WW .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (10) :2087-2094
[6]   2 EFFICIENT METHODS FOR THE CLEAVAGE OF PINANEDIOL BORONATE ESTERS YIELDING THE FREE BORONIC ACIDS [J].
COUTTS, SJ ;
ADAMS, J ;
KROLIKOWSKI, D ;
SNOW, RJ .
TETRAHEDRON LETTERS, 1994, 35 (29) :5109-5112
[7]   Potent and selective proline derived dipeptidyl peptidase IV inhibitors [J].
Edmondson, SD ;
Mastracchio, A ;
Beconi, M ;
Colwell, LF ;
Habulihaz, B ;
He, HB ;
Kumar, SJ ;
Leiting, B ;
Lyons, KA ;
Mao, A ;
Marsilio, F ;
Patel, RA ;
Wu, JK ;
Zhu, L ;
Thornberry, NA ;
Weber, AE ;
Parmee, ER .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (20) :5151-5155
[8]   Synthesis and structure-activity relationship of N-alkyl Gly-boro-Pro inhibitors of DPP4, FAP, and DPP7 [J].
Hu, Y ;
Ma, LF ;
Wu, M ;
Wong, MS ;
Li, B ;
Corral, S ;
Yu, ZZ ;
Nomanbhoy, T ;
Alemayehu, S ;
Fuller, SR ;
Rosenblum, JS ;
Rozenkrants, N ;
Minimo, LC ;
Ripka, WC ;
Szardenings, AK ;
Kozarich, JW ;
Shreder, KR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (19) :4239-4242
[9]   Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII [J].
Leiting, B ;
Pryor, KD ;
Wu, JK ;
Marsilio, F ;
Patel, RA ;
Craik, CS ;
Ellman, JA ;
Cummings, RT ;
Thornberry, NA .
BIOCHEMICAL JOURNAL, 2003, 371 (02) :525-532
[10]   Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7) [J].
Maes, MB ;
Lambeir, AM ;
Gilany, K ;
Senten, K ;
Van Der Veken, P ;
Leiting, B ;
Augustyns, K ;
Scharpé, S ;
De Meester, I .
BIOCHEMICAL JOURNAL, 2005, 386 :315-324